Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Assessment of the Inflammatory Atheromatous Plaque
NCT01608516Phase 2Terminated
- Sponsor
- Lausanne University Hospital
- Start
- Apr 2012
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-NODAGA-RGD in carotid artery disease, atheromatous plaque (AS), sponsored by Lausanne University Hospital. Started Apr 2012; status: terminated.
02
Drugs
68Ga-NODAGA-RGD
03
Conditions
carotid artery diseaseatheromatous plaque (AS)
Beyond the preview
Go deeper on NCT01608516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608516.